Literature DB >> 20715988

Anti-human CD133 monoclonal antibody that could inhibit the proliferation of colorectal cancer cells.

Wei Chen1, Feng Li, Zhi-Mou Xue, Hao-Rong Wu.   

Abstract

CD133, a five-transmembrane molecule, has been found on many types of cancers and determined to be a cancer stem cell biomarker. In this study a functional anti-human CD133 MAb 6B6 was obtained, and the specificity of this MAb was verified by flow cytometry. This MAb effectively recognized the CD133 molecule expressed on a series of malignant cell lines. Immunohistochemistry staining showed the CD133 was expressed on colorectal tumor tissue. Furthermore, we demonstrated that MAb 6B6 could inhibit the proliferation of Caco-2 cells that were derived from a human colorectal carcinoma. This functional anti-human CD133 MAb provides a valuable tool for further study of biological functions of cancer stem cell that expressed CD133.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20715988     DOI: 10.1089/hyb.2010.0019

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  1 in total

1.  An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity against Colorectal Cancer.

Authors:  Bastian J Schmied; Fabian Riegg; Latifa Zekri; Ludger Grosse-Hovest; Hans-Jörg Bühring; Gundram Jung; Helmut R Salih
Journal:  Cancers (Basel)       Date:  2019-06-07       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.